Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. (Q38947587)
Jump to navigation
Jump to search
scientific article published on 30 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. |
scientific article published on 30 April 2013 |
Statements
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice (English)
Sabrina Cipriani
Daniela Francisci
Andrea Mencarelli
Barbara Renga
Elisabetta Schiaroli
Franco Baldelli
Stefano Fiorucci
30 April 2013